258 related articles for article (PubMed ID: 24116693)
1. Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study.
Alloin AL; Barlogis V; Auquier P; Contet A; Poiree M; Demeocq F; Herrmann I; Villes V; Bertrand Y; Plantaz D; Kanold J; Chastagner P; Chambost H; Sirvent N; Michel G
Br J Haematol; 2014 Jan; 164(1):94-100. PubMed ID: 24116693
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: an LEA study.
Horwitz M; Auquier P; Barlogis V; Contet A; Poiree M; Kanold J; Bertrand Y; Plantaz D; Galambrun C; Berbis J; Villes V; Chastagner P; Sirvent N; Oudin C; Michel G
Br J Haematol; 2015 Feb; 168(4):518-25. PubMed ID: 25284463
[TBL] [Abstract][Full Text] [Related]
3. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
4. Moyamoya syndrome following childhood acute lymphoblastic leukemia.
Kikuchi A; Maeda M; Hanada R; Okimoto Y; Ishimoto K; Kaneko T; Ikuta K; Tsuchida M;
Pediatr Blood Cancer; 2007 Mar; 48(3):268-72. PubMed ID: 16615044
[TBL] [Abstract][Full Text] [Related]
5. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
[TBL] [Abstract][Full Text] [Related]
6. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
[TBL] [Abstract][Full Text] [Related]
7. The neurodevelopmental sequelae of childhood leukaemia and its treatment.
Temming P; Jenney ME
Arch Dis Child; 2010 Nov; 95(11):936-40. PubMed ID: 20980277
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
9. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
[TBL] [Abstract][Full Text] [Related]
10. Analysis of growth failure in children treated for acute lymphoblastic leukemia.
Sato J; Ninomiya T; Tsuda Y; Komazawa M; Nagata K; Iwai A; Nishikawa K; Maeda H; Ohmiya A; Ohta M
Int J Hematol; 1992 Dec; 56(3):205-12. PubMed ID: 1477332
[TBL] [Abstract][Full Text] [Related]
11. Health status and quality of life of long-term survivors of childhood acute leukemia: the impact of central nervous system irradiation.
Benadiba J; Michel G; Auquier P; Chastagner P; Kanold J; Poirée M; Plantaz D; Padovani L; Berbis J; Barlogis V; Contet A; Chambost H; Sirvent N
J Pediatr Hematol Oncol; 2015 Mar; 37(2):109-16. PubMed ID: 24936742
[TBL] [Abstract][Full Text] [Related]
12. Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia.
Lin WY; Liu HC; Yeh TC; Wang LY; Liang DC
Pediatr Blood Cancer; 2008 Mar; 50(3):523-7. PubMed ID: 17455314
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
[TBL] [Abstract][Full Text] [Related]
14. Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.
Edelstein K; D'agostino N; Bernstein LJ; Nathan PC; Greenberg ML; Hodgson DC; Millar BA; Laperriere N; Spiegler BJ
J Pediatr Hematol Oncol; 2011 Aug; 33(6):450-8. PubMed ID: 21646917
[TBL] [Abstract][Full Text] [Related]
15. Current management and challenges of malignant disease in the CNS in paediatric leukaemia.
Pui CH; Howard SC
Lancet Oncol; 2008 Mar; 9(3):257-68. PubMed ID: 18308251
[TBL] [Abstract][Full Text] [Related]
16. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB
J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
Schmiegelow K; Forestier E; Hellebostad M; Heyman M; Kristinsson J; Söderhäll S; Taskinen M;
Leukemia; 2010 Feb; 24(2):345-54. PubMed ID: 20010622
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity.
Waber DP; Silverman LB; Catania L; Mautz W; Rue M; Gelber RD; Levy DE; Goldwasser MA; Adams H; Dufresne A; Metzger V; Romero I; Tarbell NJ; Dalton VK; Sallan SE
J Clin Oncol; 2004 Jul; 22(13):2701-7. PubMed ID: 15226337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
